Developmental exposure to high doses of the synthetic xenoestrogen diethylstilbestrol (DES) has been reported to alter femur length and strength in adult mice. However, it is not known if developmental exposure to low, environmentally relevant doses of xenoestrogens alters adult bone geometry and strength. In this study we investigated the effects of developmental exposure to low doses of DES, bisphenol A (BPA), or ethinyl estradiol (EE 2 ) on bone geometry and torsional strength. C57BL/6 mice were exposed to DES, 0.1 lg/kg/day, BPA, 10 lg/kg/day, EE 2 , 0.01, 0.1, or 1.0 lg/kg/day, or vehicle from Gestation Day 11 to Postnatal Day 12 via a mini-osmotic pump in the dam. Developmental Xenoestrogen exposure altered femoral geometry and strength, assessed in adulthood by micro-computed tomography and torsional strength analysis, respectively. Low-dose EE 2 , DES, or BPA increased adult femur length. Exposure to the highest dose of EE 2 did not alter femur length, resulting in a nonmonotonic dose response. Exposure to EE 2 and DES but not BPA decreased tensile strength. The combined effect of increased femur length and decreased tensile strength resulted in a trend toward decreased torsional ultimate strength and energy to failure. Taken together, these results suggest that exposure to developmental exposure to environmentally relevant levels of xenoestrogens may negatively impact bone length and strength in adulthood.
INTRODUCTION
Xenoestrogens are synthetic chemicals that mimic endogenous steroidal estrogens. Xenoestrogens are ubiquitous in the environment and are found in both natural and synthetic products. Ethinyl estradiol (EE 2 ) is the primary estrogenic component of most combination oral contraceptives. Millions of women take oral contraceptives to prevent pregnancy, and between 2% and 5% of these women conceive due to noncompliance [1] . The babies born after such events are exposed to 0.2 to 0.5 lg/kg EE 2 during critical periods of development. There is also a growing concern about contamination of surface, ground, and drinking water sources with EE 2 [2] [3] [4] .
Bisphenol A (BPA) is a high-volume chemical, with over 5.6 billion pounds produced each year [5] . It is known to leach from the epoxy resin lining of metal food cans [6] , dental sealants [7] , and polycarbonate food containers [8] and to be liberated from thermal paper receipts [9, 10] . Other potential sources include sewage leachate, drinking water, air, and dust [11] . Calafat et al. [12] reported detectable levels of BPA and its metabolites in 92.6% of Americans. Recent evidence suggests that there is chronic human exposure to BPA, likely from multiple sources [13] . Because of their ability to interact with estrogen receptors (ER), xenoestrogens like EE 2 and BPA may act to disrupt endogenous hormone signaling.
The effects of adult exposure to estrogens are often reversible. In contrast, the effects of developmental exposure to estrogens can be irreversible as this is a critical period of cell and organ differentiation [14] . It has been suggested that some adult diseases may originate from early fetal exposure to an altered estrogen milieu. For example, millions of women were exposed in utero to the synthetic estrogen diethylstilbestrol (DES) from 1940-1971 in the mistaken belief that it would prevent miscarriage. Unfortunately it was not until young women presented with vaginal clear cell adenocarcinoma that the adverse effects of developmental DES exposure were uncovered [15] , and subsequently, developmental exposure has been linked to an increased risk of endometriosis and breast cancer [16, 17] . Although DES is no longer prescribed to pregnant women, it has been extensively used as a positive control for studying the effects of developmental xenoestrogen exposure.
Bone is an estrogen-responsive tissue and, as such, is a potential target for developmental programming by xenoestrogens. Estrogen receptors are found in osteoblasts, osteoclasts, and bone marrow cells [18] , and estrogen is generally associated with osteoblast-mediated bone formation and osteoclast-mediated bone resorption [18] . The presence of the two ERs (a and b, official symbols, ESR1 and ESR2) appears to depend on the type of bone and age of the individual [18] . Different xenoestrogens can have different affinities for the two ERs. For example, BPA has a stronger affinity for ESR2 than for ESR1 [19] [20] [21] . Thus, individual xenoestrogens may elicit unique responses from bone cells depending on the specific cell type and timing of exposure.
To date, studies of the effects of developmental xenoestrogen exposure on bone have focused primarily on high-dose xenoestrogen exposures. High-dose DES (0.5 to 3 mg/kg/day) administered on Postnatal Days 1-5 resulted in altered adult femur length and strength [22] [23] [24] [25] [26] . Exposure to other xenoestrogens has been reported to alter long bone parameters. For example, postnatal exposure to the soy isoflavones genistein and daidzein has been reported to impact adult femur geometry and strength [24, 26] .
Currently, humans are exposed to myriad xenoestrogens in our environment, typically at low doses. Because effects of xenoestrogens at high doses do not reliably predict the effects of low doses, it is essential to test the effects of developmental exposure to low, environmentally relevant levels of xenoestrogens. We report here for the first time the effects of low-dose developmental exposure to EE 2 , DES, and BPA on femur geometry and biomechanical strength in adult mice.
MATERIALS AND METHODS

Animals
All animals were housed in polysulfone cages under temperature-and lightcontrolled (12L:12D) conditions, and all experimental manipulations were performed according to an approved University of Missouri Animal Care and Use Protocol and in accord with the National Research Council's Guide for the Care and Use of Laboratory Animals [27] . Mice were fed Rodent Chow product no. 5008 (Purina, St. Louis, MO) and received acidified water ad libitum from polysulfone bottles.
C57BL/6J mice were time-mated and the presence of a vaginal plug was denoted as Gestation Day (GD) 0. On GD 11 mice were implanted with a miniosmotic pump (model 1002; Alzet, Cupertino, CA) designed to release a steady amount of treatment. According to the manufacturer, these pumps had a mean fill volume of 101 ll and a mean release rate of 0.2 ll/h. Experiment 1 mice received EE 2 (0.01, 0.1, or 1.0 lg/kg/day) or vehicle control (80% polyethylene glycol, 20% dimethyl sulfoxide), and experiment 2 mice received DES (0.1 lg/ kg/day), BPA (10 lg/kg/day), or vehicle control (80% polyethylene glycol, 20% dimethyl sulfoxide). Mice were born on GD 19 and were exposed to the chemical through lactation until Postnatal Day 12.
Female mice were group housed. Two to three females per litter were used for analysis from experiment 1 and one to two females per litter were used for analysis from experiment 2. Male mice were singly housed to avoid confounding hormone levels due to dominance hierarchies. One male per litter was used, and only males from litters in which there were two or more surviving males per litter were studied in order to minimize variation due to the prenatal hormone microenvironment.
Developmentally exposed mice were euthanized by carbon dioxide asphyxiation and cervical dislocation at 10 weeks of age (experiment 1 females), 13 weeks of age (experiment 2 females), or 23 weeks of age (experiment 2 males). These collection time points occurred after the period of femur longitudinal growth and represent a time when the bone length, mass, and mechanical properties have reached mature levels in C57BL/6 mice [28, 29] . The left femur was excised, cleaned of soft tissue, wrapped in sterile gauze, and stored in PBS at À208C. Only developmental exposure to 0.1 lg/kg/day EE 2 tended to increase body weight (4.1%) at the time of collection (t 30 ¼ À2.02, P ¼ 0.053) (data not shown).
lCT Analysis and Torsional Loading to Failure Geometric parameters were defined from excised left femurs by microcomputed tomography (lCT) scan analysis (Micro-CAT II; Siemens Medical, Malvern, PA) prior to ex vivo torsional loading to failure as previously described [30] . Briefly, femur length, periosteal major diameter (D p ) and minor diameter (d p ), endosteal major diameter (D e ), marrow cavity diameter, cortical bone width, q (derived from D e /D p ), and the polar moment of area (K) were measured or calculated based on the lCT scan.
Following lCT analyses, femur torsional strength was tested by torsional loading to failure in which the torsional loading apparatus applies an equal stress to the circumference of the bone and thus permits the bone to fail at the weakest point. Briefly, the distal and proximal ends of the left femur were embedded in a steel cylindrical holder with two diametrically opposite side windows of 7 mm in length ( Fig. 1) [30] . The holder was then placed in the test fixture, designed to apply a pure torsional load on the femur, mounted on a TA-HDi testing machine (Stable Micro Systems, Surrey, U.K.). A cross-bar prevented the proximal end of the holder-femur from rotating about its long axis while the distal end was rotated about its long axis at a constant speed of 0.75 rad/sec with a 5-kg load cell. The test machine's control software (Stable Micro Systems, Surrey, U.K.) acquired the cable force, F, in grams, and applied torque, T (Nmm) calculated using the equation T ¼ ([F À F friction in fixture ] 3 0.13006). T was plotted as a function of the relative angular displacement, h (degrees). Torsional stiffness (Ks) (Nmm/rad) of the femur's exposed test length, L, was determined as the slope of a line fit by linear regression to the initial linear region of this plot between 5 , T , 10 Nmm. Ultimate tensile strength (Su) (N/mm 2 ) of the femur's cortical bone was determined according to Roarck and Young [31] by substituting the femur's torsional ultimate strength (T max ) and its mid-shaft cross-section diameters in the equation
. The shear modulus of elasticity (G) (N/mm 2 ) of the femur's cortical bone was determined using G ¼ KsL/K according to Roarck and Young [31] . The strain energy to failure absorbed in the femur (U) (Nmm) was calculated as the work done by the testing machine on the femur-fixture assembly as the area under the T vs. h graph from T ¼ 2 to failure, T max .
Collagen Content
Hydroxyproline, an amino acid unique to collagen, was quantified in experiment 2 mice as a relative measure of femoral collagen content [32] . Following torsional loading to failure, the broken shafts were removed from the testing device, weighed, and used to determine the hydroxyproline content/mg bone as described previously [33] .
Determination of Potency of Oral and Subcutaneous Doses
The mouse uterotrophic assay was used to compare the relative potency of EE 2 via an oral and subcutaneous route of administration [34] . Mice were ovariectomized and 1 week later were given glass water bottles containing vehicle control (0.1% ethanol) or 0.67, 6.7, or 667 ng/ml EE 2 in their drinking water. Water bottles were weighed daily, and the approximate volume of water consumed was used to calculate the dose per body weight (0, 0.14, 1.0, and 48 lg/kg/day, approximately). For comparison, EE 2 was administered to another set of ovariectomized mice via a subcutaneous injection in tocopherol-stripped corn oil for 2 days at 0, 0.1, 1.0, 10, or 100 lg/kg body weight. On the third day, mice were weighed and euthanized, and the uterus was excised and weighed. The weight of the uterus was normalized to body weight.
Statistical Analysis
Data from experiment 1 were analyzed by a two-sided Student t-test to compare each developmental exposure to the vehicle, thereby maintaining fewer comparisons than degrees of freedom. Experiment 1 was performed first, and we found that low-dose developmental xenoestrogen exposure increased femur length and decreased femur strength. Therefore, our hypothesis in experiment 2 was that low-dose xenoestrogen exposure would have the same effect, so a one-sided Student t-test was used to compare developmentally exposed animals to vehicle animals of the same sex. Of the 109 femurs tested in this study, 4 femurs experienced a mechanical failure during the torsional loading to failure test and were removed from the strength analysis. Data are plotted as the percentage of difference from each vehicle for comparison of trends across the three experimental groups. 
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Whole bone strength is determined in part by the shape or geometry of the bone. Femoral geometric parameters were determined by lCT scan analysis. Overall, low-dose developmental xenoestrogen exposure increased femur length in adult mice. Developmental exposure to 0.01 and 0.1 lg/kg EE 2 increased femur length 2.6% and 2.4% (t 30 ¼À2.8, P ¼ 0.008; and t 25 ¼ À2.17, P ¼ 0.040, respectively) (Fig. 2) . Whereas exposure to the two lowest doses increased femur length, exposure to the highest dose, 1.0 lg/kg EE 2 , did not alter femur length relative to that in vehicle-treated animals, resulting in a nonmonotonic dose response.
Developmental DES exposure increased femur length 2.0% (t 12 ¼ À2.06, P ¼ 0.031) in females and tended to increase femur length 1.3% (t 9 ¼ À1.03, P ¼ 0.166) in males. Developmental BPA exposure, on the other hand, increased femur length 2.3% (t 13 ¼ À1.96, P ¼ 0.036) in males and tended to increase femur length 1.0% in females (t 14 ¼À0.84, P ¼ 0.208) (Fig. 2) .
In females, developmental xenoestrogen exposure did not alter cortical bone width, marrow cavity diameter, or q value, which is the ratio of the endosteal and periosteal mediolateral diameters (Tables 1 and 2 ). In males, developmental DES exposure increased cortical bone width 12.0% (t 9 ¼À1.84, P ¼ 0.050), decreased marrow cavity diameter 12.9% (t 9 ¼ 2.482, P ¼ 0.018), and tended to decrease q 7.3% (t 9 ¼ 1.38, P ¼ 0.100) ( Table 2 ). The trend toward decreased q was associated with a trend toward decreased endosteal mediolateral diameter of 8.7% (t 9 ¼ 1.40, P ¼ 0.098) but no change in the periosteal mediolateral diameter (data not shown). The polar moment of area, the overall cortical bone cross-section area distribution from its center, was not altered by developmental treatment, suggesting that changes in marrow diameter and cortical bone width in DES-exposed males are reflective of a change in geometry rather than a change in the amount of bone present.
Bone Material Properties
The material properties of the bone describe the strength and stiffness of the material the bone is made of, regardless of any geometric adaptations, and also contribute to whole bone strength. The material properties of tensile strength and shear modulus of elasticity are calculated by removing the geometric component from the whole bone measurement's torsional ultimate strength and torsional stiffness, respectively. Developmental exposure to EE 2 and DES but not BPA decreased tensile strength (Fig. 3) . Developmental exposure to EE 2 decreased tensile strength 13.9%, 8.1%, and 10.9% in 0.01, 3) .
Whole Bone Biomechanical Properties
The whole bone biochemical properties of torsional ultimate strength, torsional stiffness, and energy to failure were determined by torsional loading to failure. The combined effect of increased femur length and decreased material strength resulted in a trend toward decreased torsional ultimate strength (Fig. 4) . There was no effect of developmental xenoestrogen exposure on torsional stiffness (Tables 1 and 2) .
Energy to failure describes the total amount of torsional energy the bone can withstand prior to fracture. Developmental exposure to 1.0 EE 2 tended to decrease energy to failure 12.2% (t 27 ¼ 1.61, P ¼ 0.118). Developmental exposure to DES decreased energy to failure 18.9% (t 12 ¼ 2.17, P ¼ 0.026) in females and tended to decrease energy to failure 15.0% (t 5.96 ¼ 1.59, P ¼ 0.082) in males (Fig. 5) . Developmental exposure to BPA tended to decrease energy to failure by 10.3% (t 14 ¼ 1.40, P ¼ 0.092) in females but had no effect on energy to failure in males.
Collagen Content
Bone is a composite material made up of two main contributing components: the organic phase (mainly collagen type I) and the mineral phase (primarily hydroxyapatite, the mineral form of calcium apatite). The correct ratio of the two components is important, as too much mineral leads to brittle bones while too little mineral results in weak bone [35] . Femur diaphyseal collagen content was measured by quantifying hydroxyproline content in experiment 2 animals. Collagen content was not altered by developmental xenoestrogen exposure (data not shown). The mineral phase was not examined in this study. PELCH ET AL.
Determination of Potency of Oral and Subcutaneous Doses
The mouse uterotrophic assay was used to compare the potency of EE 2 administered subcutaneously vs. orally in the drinking water. Mice were ovariectomized in adulthood and given an estrogen challenge with EE 2 via two daily subcutaneous injections or via their drinking water. EE 2 showed similar dose responses in stimulation of uterine wet weight gain and exhibited half maximal effective concentration values of 5.3 and 5.5 lg/kg for subcutaneous and oral routes of administration, respectively (Fig. 6 ).
DISCUSSION
We report for the first time the ability of low-dose developmental exposure to EE 2 , DES, or BPA to permanently program adult femoral geometry and biomechanical strength. Developmental exposure to low doses of EE 2 , DES, and BPA increased adult femur length. Developmental exposures to EE 2 and DES decreased the tensile strength of the material composing the bone. As depicted in Figure 7 , the overall ability for a bone to withstand torsional breaking is a combination of these two attributes, the geometry and the FIG. 5. Developmental xenoestrogen exposure tends to decrease femur energy to failure. Mice were developmentally exposed to vehicle or EE 2 (0.01, 0.1, or 1 lg/kg) in experiment 1 or vehicle, DES (0.1 lg/kg/day), or BPA (10 lg/kg/day) in experiment 2, and femur energy to failure was measured by torsional loading in adulthood as described in the text. Data are means 6 SEM. (N ¼ 16, 18, 15 or 13 for experiment 1 females; 6, 8 , or 10 for experiment 2 females; and 6, 4, or 9 for experiment 2 males.) *P , 0.05, and # P , 0.100 compared to sex-matched vehicle within each experiment.
LOW DOSE DEVELOPMENTAL XENOESTROGENS AND BONE material property of the bone. In this case, an increase in length with a concurrent decrease in material strength tended to cause a decrease in torsional ultimate strength and ultimately a trend toward decreased energy to failure. Thus, bones from developmentally exposed animals could not withstand as large a torsional force prior to breaking as vehicle-exposed animals. This suggests an overall negative impact of weaker bones that may be more likely to fracture.
Doses Used in the Current Study Are Within the Expected Range of Human Exposure
The doses of EE 2 and BPA used in this study were selected based on current predicted human exposures. Oral contraceptive pills presently on the market contain 20 to 50 lg of EE 2 , resulting in a daily oral dose of approximately 0.2 to 0.5 lg/kg [36] . In this study, we showed using the well-established mouse uterotrophic assay that an oral dose and a subcutaneous dose of EE 2 are equivalent. Thus, the subcutaneous doses used in the developmental exposure paradigm of 0.01, 0.1, and 1 lg/ kg EE 2 bracket the range of current human exposures to EE 2 .
The dose of BPA used in the current study is within the range of current human exposure. The reported range of human exposure to BPA varies widely; however, the concentration in human serum has been consistently reported to be approximately 1 ng/ml [37] . This circulating level is within the range measured in neonatal rats after a 10 lg/kg subcutaneous dose of BPA, which is the same dose and route of administration used in the current study [37, 38] . The dose of DES used in this study was not chosen to replicate past human exposures of 0.2 to 1.8 mg/kg/day [39] [40] [41] but instead was chosen as a low-dose positive control, as similar doses have been reported to result in programming events in many estrogen sensitive endpoints [42] .
Effects of High Versus Low Doses of Developmental Xenoestrogens on Adult Bone
Previous studies have reported positive effects on femur geometry and strength following high doses of developmental DES exposure [24, 25, [43] [44] [45] . Migliaccio et al. [43] have shown that developmental exposure to 100 lg/kg DES, which is 1000 times greater than the dose used in the current study, resulted in shorter femurs that had increased total bone area and FIG. 7. Schematic shows major trends and relationship between endpoints measured. Whole bone strength parameters energy to failure, torsional stiffness, and torsional ultimate strength were determined by torsional loading to failure. Whole bone strength is a function of the geometry of the bone and the material properties comprising the bone. Femoral geometry was determined by micro-CT analysis. The material properties of shear modulus of elasticity and tensile strength are calculated by essentially subtracting any geometric adaptations of the bone from the whole bone parameters of torsional stiffness and torsional ultimate strength, respectively. Material properties of the bone are a function of the organic and mineral phases, which comprise the two-component system of bone. Arrows indicate effects of developmental xenoestrogen exposure on each parameter, while dashes indicate unaffected parameters.
PELCH ET AL. calcium content. These changes were the result of increased osteoblast activity as determined by an increased mineral apposition rate [43] and decreased resorption rate due to a decrease in the number of osteoclast cells [44, 45] . Following early postnatal exposure to 2 mg/kg/day DES, Kaludjerovic and Ward [25, 26] reported increased femoral strength and stiffness in female mice only. It is interesting that at the low doses used in the current study, females and males responded similarly to developmental DES, while males were relatively insensitive to the effects on functional strength of high dose DES.
Whereas developmental exposure to high doses of DES resulted in positive effects on adult femoral geometry, in the current study, low doses of DES and two other xenoestrogens, EE 2 and BPA, had the opposite effect on femoral geometry, resulting in longer femurs in adulthood and negative effects on bone strength. Hotchkiss et al. [46] also recently reported opposite effects at high (6 lg/kg) and low (0.2 lg/kg) doses of EE 2 on female femur length in rats exposed to EE 2 from preconception until they were euthanized at 20 weeks of age. Taken together, current and previous work provides further support for the fact that low-dose effects cannot be predicted from high-dose studies due to the nonmonotonic nature of endocrine responsive endpoints [47] .
The increase in length observed following low-dose xenoestrogen exposure was accompanied by decreased tensile strength in DES-and EE 2 -exposed mice and an overall trend toward decreased torsional ultimate strength and energy to failure. The mechanostat theory postulates that bone responds to changes in loading with alterations in material and/or architecture [48] [49] [50] [51] . All else being equal, bones that are short or wide can withstand greater torsional loads than those that are long or thin.
The mechanism behind the changes caused by low-dose developmental xenoestrogen exposure is as yet unclear and should be the focus of further studies. The decreased tensile strength may be associated with increased cortical porosity and/or altered mineral composition. Although analyses of mineral composition and matrix architecture were beyond the scope of the present study, future studies should include sensitive techniques such as neutron activation analysis to evaluate the mineral component of the bone as bone mineral content and bone mineral density in adult humans is highly associated with later fracture risk [52] [53] [54] . Previous work indicated that early postnatal high-dose DES exposure decreased trabecular separation and tended to increase trabecular number, both of which are associated with increased bone mineral density [24, 25, 52, 55] . Therefore, additional investigations evaluating trabecular bone should be considered, as it is possible that low-dose developmental exposure resulted in increased trabecular separation, decreased trabecular number and/or volume, and as a result, decreased bone density [52, 55] .
Comparison of Effects of Developmental Exposure to EE 2 , DES, and BPA Developmental exposure to low-dose (0.01 and 0.1 lg/kg) EE 2 and DES resulted in similar bone profiles. Both chemicals increased femur length and decreased tensile strength, which was reflected as a trend toward decreased torsional ultimate strength. The chemicals differed, however, in that developmental DES exposure but not low-dose developmental EE 2 exposure tended to decrease the overall energy the bones could absorb prior to breaking.
Compared to developmental exposure to EE 2 and DES, developmental exposure to BPA caused few significant alterations in bone strength. In male animals, developmental exposure to BPA increased femur length but had no effect on femur strength. The effects of developmental exposure of BPA on females were more similar to those observed in females exposed to EE 2 or DES with trends toward decreased torsional ultimate strength and energy to failure in BPA-exposed females. These are likely related to a change in shape of the bone and not due to differences in the material comprising the bone, because the shear modulus of elasticity and torsional stiffness were found not to be different in these animals.
Developmental programming of the femur by BPA differed from that by DES and EE 2 . This is possibly because BPA is mechanistically distinct from DES and EE 2 . Compared to DES and EE 2 , BPA is a weak estrogen that preferentially binds to ESR2 rather than ESR1. Additionally, BPA binds the estrogenrelated receptor with much higher affinity than either of the classical ESRs [19, 56, 57] . It is also possible that these mechanistic differences are enhanced by differential expression of the ESRs and ESRRs in fetal bone [58, 59] .
In conclusion, this study demonstrates for the first time that low-dose developmental exposure to xenoestrogens at levels relevant to current human exposure negatively impacts adult femoral geometry and strength in mice. These studies suggest that bones from developmentally exposed animals are more susceptible to fracture. Although pregnant women are no longer prescribed DES, they are in fact, chronically exposed to myriad chemicals in the environment that are capable of disrupting estrogen signaling, including BPA, EE 2 , and other pharmaceuticals, pesticides, detergents, and naturally occurring phytoestrogens and mycoestrogens. Importantly, most humans are not likely to be exposed to estrogen-disrupting chemicals in isolation and are more likely exposed to many at any given time, and there is potential for additive effects. Taken together, the results from the current study and the potential for mixtures of chemicals to cause additive effects suggest that humans exposed to xenoestrogens while in the womb may have an increased risk of fracture due to alterations in bone geometry and material strength. Currently, this association has not been examined epidemiologically.
